Sensor-derived glycaemic metrics in pregnant women with type 1 diabetes randomised to faster-acting insulin aspart or insulin aspart: a secondary analysis of the CopenFast trial

被引：0
|
作者：
Soholm, J. C. [1 ,2 ]
Norgaard, S. K. [1 ,2 ]
Norgaard, K. [2 ,3 ]
Clausen, T. D. [1 ,2 ]
Damm, P. [1 ,2 ]
Mathiesen, E. [1 ,2 ]
Ringholm, L. [1 ,2 ]
机构：
[1] Rigshosp, Ctr Pregnant Women Diabet, Copenhagen, Denmark
[2] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark
[3] Steno Diabet Ctr, Herlev, Denmark
来源：
DIABETOLOGIA | 2024年 / 67卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
462
引用
收藏
页码：S229 / S229
页数：1
相关论文
共 50 条
  • [1] Sensor-derived glycaemic metrics in pregnant women with type 1 diabetes randomised to faster acting insulin aspart or insulin aspart-A secondary analysis of the CopenFast trial
    Soholm, Julie C.
    Norgaard, Sidse K.
    Norgaard, Kirsten
    Clausen, Tine D.
    Damm, Peter
    Mathiesen, Elisabeth R.
    Ringholm, Lene
    DIABETIC MEDICINE, 2025, 42 (01)
  • [2] Copenfast trial: foetal growth and glycaemic control in pregnant women with type 1 or type 2 diabetes randomised to faster-acting insulin aspart or insulin aspart
    Norgaard, S.
    Soholm, J.
    Mathiesen, E.
    Norgaard, K.
    Clausen, T.
    Holmager, P.
    Do, N.
    Damm, P.
    Ringholm, L.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S122 - S122
  • [3] CopenFast Trial-Fetal Growth and Glycemic Control in Pregnant Women with Type 1 or Type 2 Diabetes Using Faster-Acting Insulin Aspart or Insulin Aspart-A Randomized Controlled Trial
    Noergaard, Sidse K.
    Mathiesen, Elisabeth R.
    Norgaard, Kirsten
    Clausen, Tine D.
    Soholm, Julie
    Holmager, Pernille
    Do, Nicoline C.
    Damm, Peter
    Ringholm, Lene
    DIABETES, 2023, 72
  • [4] IMPROVED POSTPRANDIAL GLYCAEMIC CONTROL WITH FASTER-ACTING INSULIN ASPART VS INSULIN ASPART IN SUBJECTS WITH TYPE 1 DIABETES USING CSII IN PUMPS
    Bode, B. W.
    Hyveled, L.
    Tamer, S. C.
    Demissie, M.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2016, 18 : A40 - A40
  • [5] Faster-acting insulin aspart improves postprandial glycaemia versus insulin aspart in patients with type 1 diabetes mellitus
    Heise, T.
    Haahr, H.
    Jensen, L.
    Erichsen, L.
    Hompesch, M.
    DIABETOLOGIA, 2014, 57 : S57 - S57
  • [6] FASTER-ACTING INSULIN ASPART IMPROVES POSTPRANDIAL GLYCAEMIA VERSUS INSULIN ASPART IN PATIENTS WITH TYPE 1 DIABETES MELLITUS
    Heise, T.
    Haahr, H.
    Jensen, L.
    Erichsen, L.
    Hompesch, M.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2015, 17 : A5 - A6
  • [7] Faster-acting insulin aspart reduces glycaemic variability in sensor-augmented pump treated type 1 diabetes patients
    Moreno-Fernandez, Jesus
    Garcia-Seco, Jose Alberto
    Virlaboa-Cebrian, Rita
    Seco, Angela Maria
    Munoz-Rodriquez, Jose Ramon
    Gomez-Romero, Francisco Javier
    ENDOCRINOLOGIA DIABETES Y NUTRICION, 2023, 70 (06): : 389 - 395
  • [8] Faster-acting insulin aspart versus insulin aspart in the treatment of type 1 or type 2 diabetes during pregnancy and post-delivery (CopenFast): an open-label, single-centre, randomised controlled trial
    Norgaard, Sidse K.
    Soholm, Julie C.
    Mathiesen, Elisabeth R.
    Norgaard, Kirsten
    Clausen, Tine D.
    Holmager, Pernille
    Do, Nicoline C.
    Damm, Peter
    Ringholm, Lene
    LANCET DIABETES & ENDOCRINOLOGY, 2023, 11 (11): : 811 - 821
  • [9] Double-blind mealtime faster-acting insulin aspart vs insulin aspart in basal-bolus improves glycaemic control in Type 1 diabetes: the onset 1 trial
    Russell-Jones, D.
    Bode, B. W.
    De Block, C.
    Franek, E.
    Heller, S.
    Mathieu, C.
    Philis-Tsimikas, A.
    Rose, L.
    Woo, V.
    Osterskov, A. B.
    Graungaard, T.
    Bergenstal, R.
    DIABETIC MEDICINE, 2017, 34 : 8 - 8
  • [10] Improved postprandial glycaemic control with faster-acting insulin aspart in individuals with type 1 diabetes using CSII
    Bode, B. W.
    Hyveled, L.
    Tamer, S. C.
    Ybanez, P.
    Demissie, M.
    DIABETOLOGIA, 2015, 58 : S19 - S19
12345